Artelon has filed a notice of an exempt offering of securities to raise $30,000,004.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Artelon is raising $30,000,004.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Aaron Smith played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Artelon
Artelon is the leader in dynamic augmentation of tendon and ligament reconstruction. Specifically designed bio-textiles resiliently reinforce the repair of soft tissue: uniquely restoring native motion, resisting the degradation of reconstruction strength, and supporting tendon and ligament regeneration. Dynamic innovations focused on getting people back to motion faster, stronger, and more stable.
To learn more about Artelon, visit http://www.artelon.com/
Contact:
Aaron Smith, Chief Executive Officer
901-598-8510
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.